Effect of directly observed preventive therapy for latent tuberculosis infection in San Francisco

被引:0
作者
White, MC
Gournis, E
Kawamura, M
Menendez, E
Tulsky, JP
机构
[1] Univ Calif San Francisco, Community Hlth Syst, San Francisco, CA 94143 USA
[2] San Francisco Dept Publ Hlth, TB Clin, San Francisco, CA USA
[3] Toronto Publ Hlth, Communicable Dis Surveillance Unit, Toronto, ON, Canada
[4] Univ Calif San Francisco, Dept Internal Med, Posit Hlth Program, San Francisco, CA USA
关键词
latent tuberculosis; adherence; directly observed therapy;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
SETTING: San Francisco TB Clinic instituted a directly observed preventive therapy (DOPT) program for treatment of persons with latent TB infection in 1996. OBJECTIVE: To examine therapy completion for latent tuberculosis infection before and after implementation of the DOPT program. DESIGN : Medical records were analyzed for patients at the San Francisco TB Clinic referred from high-risk sites for the periods 1993-1994 (n = 619) and 1997 June 1998 (n = 460). Treatment completion and time of therapy were analyzed comparing DOPT to self-administered therapy (SAT). RESULTS: More DOPT patients completed treatment (70.3%) than SAT patients (47.9%) (P < 0.001). Controlling for sex, age, race/ethnic group and cohort, patients on DOPT were nearly twice as likely to complete therapy (OR 1.93, 95%CI 1.25-3.00). CONCLUSION: DOPT is a successful strategy. Combined with targeted testing, DOPT can have an important impact in areas with traditionally low rates of treatment adherence.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 29 条
[1]  
[Anonymous], 1998, MMWR Recomm Rep, V47, P1
[2]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[3]  
[Anonymous], 1999, MMWR, V48, DOI [DOI 10.1037/E547822006-001, 10.1037/e547822006-001]
[4]   TREATMENT OF TUBERCULOSIS AND TUBERCULOSIS INFECTION IN ADULTS AND CHILDREN [J].
BASS, JB ;
FARER, LS ;
HOPEWELL, PC ;
OBRIEN, R ;
JACOBS, RF ;
RUBEN, F ;
SNIDER, DE ;
THORNTON, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (05) :1359-1374
[5]  
Binkin NJ, 1999, INT J TUBERC LUNG D, V3, P663
[6]   A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users [J].
Chaisson, RE ;
Barnes, GL ;
Hackman, J ;
Watkinson, L ;
Kimbrough, L ;
Metha, S ;
Cavalcante, S ;
Moore, RD .
AMERICAN JOURNAL OF MEDICINE, 2001, 110 (08) :610-615
[7]  
Chaulk CP, 2000, INT J TUBERC LUNG D, V4, pS55
[8]   Differences in contributing factors to tuberculosis incidence in US-born and foreign-born persons [J].
Chin, DP ;
DeRiemer, K ;
Small, PM ;
de Leon, AP ;
Steinhart, R ;
Schecter, GF ;
Daley, CL ;
Moss, AR ;
Paz, EA ;
Jasmer, RM ;
Agasino, CB ;
Hopewell, PC .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (06) :1797-1803
[9]  
Davidson H, 2000, INT J TUBERC LUNG D, V4, P860
[10]   Patient satisfaction with care at directly observed therapy programs for tuberculosis in New York City [J].
Davidson, H ;
Smirnoff, M ;
Klein, SJ ;
Burdick, E .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1999, 89 (10) :1567-1570